| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/01/2012 | CN101247795B 用于治疗与中枢神经系统（cns）相关疾病的方法和组合物 A method for the treatment of central nervous system (cns) related diseases and compositions |
| 02/01/2012 | CN101224282B 一种治疗小儿厌食症的药物组合物及其制备方法 A method of treating anorexia pharmaceutical composition and its preparation method |
| 02/01/2012 | CN101176743B 一种治疗冠心病心绞痛的中药 A traditional Chinese medicine treatment of angina pectoris |
| 02/01/2012 | CN101175484B 可分散波生坦片剂 Dispersible tablets bosentan |
| 02/01/2012 | CN101153053B 骨生肽、其制备方法和其药物组合物与用途 Bone peptides, their preparation and pharmaceutical compositions and uses thereof |
| 02/01/2012 | CN101129381B 含β-内酰胺类抗生素和离子螯合剂的抗生素复方 Contained within the β- lactam antibiotics and antibiotic ion chelating compound |
| 02/01/2012 | CN101099765B 一种柴黄制剂的制备方法 Preparation method of preparation Chaihuang |
| 02/01/2012 | CN101085002B 一种含冰片的复方丹参冻干粉针剂及其制备方法 Compound Salvia containing freeze-dried powder borneol and its preparation method |
| 02/01/2012 | CN101019824B 一种含有丹参丹酚酸a的口服药物组合物的制备方法 A method of preparing a Salvia Sal oral pharmaceutical compositions containing |
| 01/31/2012 | US8106228 Microprotein-inactivating ultrafine metal particles |
| 01/31/2012 | US8105652 Methods of making decomposable thin films of polyelectrolytes and uses thereof |
| 01/31/2012 | US8105637 health food and drink contains the pure plant extract, is for patients with abnormality in cerebral blood flow and metabolism of brain disorder; nutraceuticals; free of proanthocyanidins |
| 01/31/2012 | US8105631 Opioid agonist/antagonist combinations |
| 01/31/2012 | US8105630 Composition containing medicine extremely slightly soluble in water being excellent in eluting property and method for preparation thereof |
| 01/31/2012 | US8105629 Collagen gel and process of producing the same |
| 01/31/2012 | US8105628 Mixture of biocompatible putty containing bulking agent, metal compound and polymer |
| 01/31/2012 | US8105627 Extended release venlafaxine tablet formulation |
| 01/31/2012 | US8105626 Granules containing acid-unstable chemical in large amount |
| 01/31/2012 | US8105625 capsule; polyol plasticizer ( such as glycerol, propylene glycol, polyvinyl alcohol, sorbitol, pluronic and maltitol), dissolution enhancing agent (e.g. maltose, lactose, sorbitol, mannitol, gluconic acid lactone, xylitol, maltitol, and isomalt); filled with a drug and excipient |
| 01/31/2012 | US8105624 Topical patch for pain relief using cooling agent |
| 01/31/2012 | US8105622 Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| 01/31/2012 | US8105583 Solubilized CoQ-10 |
| 01/31/2012 | US8105279 Dispensing fluid from an infusion pump system |
| 01/31/2012 | US8105268 Safety limits for closed-loop infusion pump control |
| 01/31/2012 | US8105082 Compositions for removing stains from dental surfaces and methods of making and using the same |
| 01/31/2012 | US8104482 Method for treating a thrombosis |
| 01/31/2012 | US8104433 Long-lasting gustatory and/or olfactory aversion veterinary compositions for behavior modification |
| 01/31/2012 | CA2558233C Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/31/2012 | CA2546476C Pharmaceutical preparation containing gabapentin |
| 01/31/2012 | CA2524907C Polyethylene glycol/polycation block copolymers |
| 01/31/2012 | CA2509449C Lyophilized preparation of stabilized anthracycline compounds |
| 01/31/2012 | CA2508022C Mastitis treatment |
| 01/31/2012 | CA2462826C Delivery of hydrogel compositions as a fine mist |
| 01/31/2012 | CA2447990C Encapsulation of nanosuspensions in liposomes and microspheres |
| 01/31/2012 | CA2393251C Eliciting hcv-specific antibodies |
| 01/28/2012 | CA2747181A1 Adhesive patch and patch preparation |
| 01/27/2012 | DE212009000180U1 Bandage für die Behandlung von Gelenkschmerz umfassend mindestens zwei transdermale Pflaster Bandage for treating joint pain comprising at least two transdermal patches |
| 01/26/2012 | WO2012012772A2 Drug eluting hydrogels for catheter delivery |
| 01/26/2012 | WO2012012546A2 METHOD OF CONTROLLING INITIAL DRUG RELEASE OF siRNA FROM SUSTAINED-RELEASE IMPLANTS |
| 01/26/2012 | WO2012012541A2 SUSTAINED RELEASE siRNA FOR OCULAR DRUG DELIVERY |
| 01/26/2012 | WO2012012507A2 Methods, inserts, and systems useful for endodontic treatment |
| 01/26/2012 | WO2012012476A1 Pharmaceutical composition with enhanced solubility characteristics |
| 01/26/2012 | WO2012012417A1 Transdermal adhesive compositions, devices, and methods |
| 01/26/2012 | WO2012012370A1 Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| 01/26/2012 | WO2012012347A2 Methods of intravenous administration of glyburide and other drugs |
| 01/26/2012 | WO2012012264A1 Methods and compositions for the treatment of allergy |
| 01/26/2012 | WO2012012184A2 Ophthalmic devices containing chemokine antagonists |
| 01/26/2012 | WO2012012162A2 Core-sheath implant device having an inner core lobe |
| 01/26/2012 | WO2012011882A1 A combination of atorvastatin and aspirin to be used in the treatment of cardiovascular diseases |
| 01/26/2012 | WO2012011847A1 Substituted indoles, antiviral active component, method for producing and using same |
| 01/26/2012 | WO2012011840A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 01/26/2012 | WO2012011740A2 Method for preparing microspheres and microspheres produced thereby |
| 01/26/2012 | WO2012011566A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | WO2012011429A1 Sheet preparation for tissue adhesion |
| 01/26/2012 | WO2012011407A1 Therapeutic agent for disease accompanied by epileptic waves |
| 01/26/2012 | WO2012011192A1 Tacrolimus-containing oil-in-water type creamy composition |
| 01/26/2012 | WO2012011133A1 Clay and method for its production |
| 01/26/2012 | WO2012010980A2 Improved apparatus and process for making soft gel capsules |
| 01/26/2012 | WO2012010977A2 Single daily dosage form for prevention and treatment of metabolic syndrome |
| 01/26/2012 | WO2012010883A2 Pharmaceutical depot for 5-fluoro-2 [ [ (1s) -1- (5-fluoro-2-pyridyl)ethyl]amino]-6-[(5-isopropoxy-1h-pyrazol-3-yl)amino]pyridine-3-carbonitrile |
| 01/26/2012 | WO2012010854A1 Inhalation formulations comprising carmoterol in combination with a corticosteroid |
| 01/26/2012 | WO2012010669A2 Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer |
| 01/26/2012 | WO2012010587A1 Sulforaphane stabilization |
| 01/26/2012 | WO2012010478A1 Combination of siloxane and active ingredient for treating dental disorder |
| 01/26/2012 | WO2012010159A1 Biodegradable nano-, meso-, and micro-polymer particles for maintaining a low surface tension in the lung and for protecting the pulmonary surfactant |
| 01/26/2012 | WO2012010022A1 New use of hesperetin |
| 01/26/2012 | WO2012009973A1 Antiparkinsonian drug-loaded microsphere composition and use thereof |
| 01/26/2012 | WO2011156710A3 Combination therapy with lisdexamphetamine and extended release guanfacine |
| 01/26/2012 | WO2011156030A3 High oil-content emollient aerosol foam compositions |
| 01/26/2012 | WO2011152689A9 Method for purifying fucoxanthin derived from seaweed |
| 01/26/2012 | WO2011151786A3 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 01/26/2012 | WO2011151733A3 Fexofenadine-based composition and preparation process therefor |
| 01/26/2012 | WO2011147026A3 A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide |
| 01/26/2012 | WO2011135585A3 Aqueous pharmaceutical solution of ciclesonide |
| 01/26/2012 | WO2011118960A3 Method for preparing nano-particles |
| 01/26/2012 | WO2011106702A3 Sustained delivery of therapeutic agents to an eye compartment |
| 01/26/2012 | WO2011100295A3 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
| 01/26/2012 | WO2011098194A3 Pharmaceutical mini-tablets for sustained release of flecainide acetate |
| 01/26/2012 | WO2011080716A3 Pharmaceutical composition for modified delivery of actives |
| 01/26/2012 | WO2011063775A3 Pectin complexes of sartans and pharmaceutical compositions based thereon |
| 01/26/2012 | WO2011023540A3 Use of cycloaliphatic diols as biocides |
| 01/26/2012 | WO2010143070A3 Amorphous varenicline tartrate co-precipitates |
| 01/26/2012 | US20120022165 Transdermal compositions |
| 01/26/2012 | US20120022159 Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof |
| 01/26/2012 | US20120022089 Solid Pharmaceutical Dosage Form |
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120021971 Functional Food Product Comprising Heat Shock Protein or a Hydrolysate Thereof |
| 01/26/2012 | US20120021906 Fungal inoculant compositions |
| 01/26/2012 | US20120021059 Solid preparation |
| 01/26/2012 | US20120021058 Process for making dry and stable hemostatic compositions |
| 01/26/2012 | US20120021057 Once-daily oral ir/cr pramipexole formulation |
| 01/26/2012 | US20120021056 Methods and Systems for Inducing Immunologic Tolerance to Non-Self Antigens |
| 01/26/2012 | US20120021055 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 01/26/2012 | US20120021054 Tablet formulation of ezatiostat |
| 01/26/2012 | US20120021053 Controlled release and taste-masking oral pharmaceutical composition |
| 01/26/2012 | US20120021052 Controlled release and taste masking oral pharmaceutical composition |
| 01/26/2012 | US20120021051 Zaleplon gastroretentive drug delivery system |
| 01/26/2012 | US20120021050 Nanoparticle formulated glycolipid antigens for immunotherapy |
| 01/26/2012 | US20120021049 Single Daily Dosage Form for Prevention and Treatment of Metabolic Syndrome |
| 01/26/2012 | US20120021048 Combination Dosage Compositions Comprising a Cholesterol-Lowering Agent, a Renin-Angiotensin System Inhibitor, an Antioxidant Agent and an Antiplatelet Agent for Treatment and Prevention of Cardiovascular Disease |